Papers
1
Total Citations
22
H-Index
1
About
Yanli Li is a health economics and outcomes researcher whose work sits at the intersection of surgical innovation and healthcare value assessment. Li's most notable contribution to date is a rigorous systematic literature review examining the cost-effectiveness of robotic-assisted radical prostatectomy (RARP) for localised prostate cancer, published in 2022 and accumulating 22 citations — a strong indication of its relevance to both clinical and health policy communities. By synthesising economic evidence across multiple databases, including PubMed, Embase, and Scopus, and comparing RARP against established open and laparoscopic surgical approaches, Li's work addresses a critical question in modern urology: whether the premium cost of robotic technology translates into meaningful value for patients and healthcare systems. This type of comparative effectiveness research is increasingly vital as hospitals and policymakers navigate decisions about expensive surgical technologies. Li's methodology demonstrates a commitment to evidence-based health technology assessment, and their findings offer a structured framework for clinicians, administrators, and policymakers seeking to justify or scrutinise investment in robotic surgical platforms. Li's research represents a valuable contribution to the global conversation on sustainable, high-quality cancer care delivery.
Research Focus
Key Achievements
Top Papers
- 1